These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23563236)

  • 1. Highly variable clinical manifestations in a large family with a novel GATA2 mutation.
    Mutsaers PG; van de Loosdrecht AA; Tawana K; Bödör C; Fitzgibbon J; Menko FH
    Leukemia; 2013 Nov; 27(11):2247-8. PubMed ID: 23563236
    [No Abstract]   [Full Text] [Related]  

  • 2. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies.
    Leubolt G; Redondo Monte E; Greif PA
    IUBMB Life; 2020 Jan; 72(1):151-158. PubMed ID: 31785092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies.
    Wang X; Muramatsu H; Okuno Y; Sakaguchi H; Yoshida K; Kawashima N; Xu Y; Shiraishi Y; Chiba K; Tanaka H; Saito S; Nakazawa Y; Masunari T; Hirose T; Elmahdi S; Narita A; Doisaki S; Ismael O; Makishima H; Hama A; Miyano S; Takahashi Y; Ogawa S; Kojima S
    Haematologica; 2015 Oct; 100(10):e398-401. PubMed ID: 26022708
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
    Hahn CN; Brautigan PJ; Chong CE; Janssan A; Venugopal P; Lee Y; Tims AE; Horwitz MS; Klingler-Hoffmann M; Scott HS
    Leukemia; 2015 Aug; 29(8):1795-7. PubMed ID: 25676417
    [No Abstract]   [Full Text] [Related]  

  • 5. The evolution of cellular deficiency in GATA2 mutation.
    Dickinson RE; Milne P; Jardine L; Zandi S; Swierczek SI; McGovern N; Cookson S; Ferozepurwalla Z; Langridge A; Pagan S; Gennery A; Heiskanen-Kosma T; Hämäläinen S; Seppänen M; Helbert M; Tholouli E; Gambineri E; Reykdal S; Gottfreðsson M; Thaventhiran JE; Morris E; Hirschfield G; Richter AG; Jolles S; Bacon CM; Hambleton S; Haniffa M; Bryceson Y; Allen C; Prchal JT; Dick JE; Bigley V; Collin M
    Blood; 2014 Feb; 123(6):863-74. PubMed ID: 24345756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.
    Wlodarski MW; Hirabayashi S; Pastor V; Starý J; Hasle H; Masetti R; Dworzak M; Schmugge M; van den Heuvel-Eibrink M; Ussowicz M; De Moerloose B; Catala A; Smith OP; Sedlacek P; Lankester AC; Zecca M; Bordon V; Matthes-Martin S; Abrahamsson J; Kühl JS; Sykora KW; Albert MH; Przychodzien B; Maciejewski JP; Schwarz S; Göhring G; Schlegelberger B; Cseh A; Noellke P; Yoshimi A; Locatelli F; Baumann I; Strahm B; Niemeyer CM;
    Blood; 2016 Mar; 127(11):1387-97; quiz 1518. PubMed ID: 26702063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Korean case of Emberger syndrome (primary lymphedema with myelodysplasia) with a novel GATA2 gene mutation.
    Seo SK; Kim KY; Han SA; Yoon JS; Shin SY; Sohn SK; Moon JH
    Korean J Intern Med; 2016 Jan; 31(1):188-90. PubMed ID: 26767875
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
    Kozyra EJ; Göhring G; Hickstein DD; Calvo KR; DiNardo CD; Dworzak M; de Haas V; Starý J; Hasle H; Shimamura A; Fleming MD; Inaba H; Lewis S; Hsu AP; Holland SM; Arnold DE; Mecucci C; Keel SB; Bertuch AA; Tawana K; Barzilai S; Hirabayashi S; Onozawa M; Lei S; Alaiz H; Andrikovics H; Betts D; Beverloo BH; Buechner J; Čermák M; Cervera J; Haus O; Jahnukainen K; Manola KN; Nebral K; Pasquali F; Tchinda J; Turkiewicz D; Van Roy N; Zemanova Z; Pastor VB; Strahm B; Noellke P; Niemeyer CM; Schlegelberger B; Yoshimi A; Wlodarski MW
    Blood; 2021 Dec; 138(23):2441-2445. PubMed ID: 34469508
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of GATA2-related myelodysplastic syndrome with unbalanced translocation der(1;7)(q10;p10).
    Kurata T; Shigemura T; Muramatsu H; Okuno Y; Nakazawa Y
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28066994
    [No Abstract]   [Full Text] [Related]  

  • 11. Connecting the Dots From Fever of Unknown Origin to Myelodysplastic Syndrome: GATA2 Haploinsufficiency.
    Montiel-Esparza R; Reys B; Rogers ZR; Evans AS; Wysocki CA; Timmons C; Dickerson KE
    J Pediatr Hematol Oncol; 2020 Jul; 42(5):e365-e368. PubMed ID: 31033783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trilineage Dysplasia in an Adolescent With Germline GATA2 Mutation.
    Gardner JA; Devitt KA
    J Pediatr Hematol Oncol; 2019 Jul; 41(5):392-393. PubMed ID: 30933029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
    Vinh DC; Palma L; Storring J; Foulkes WD
    J Pediatr Hematol Oncol; 2018 May; 40(4):e225-e228. PubMed ID: 29620682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel germline GATA2 frameshift mutation with a premature stop codon in a family with congenital sensory hearing loss and myelodysplastic syndrome.
    Nakazawa H; Yamaguchi T; Sakai H; Maruyama M; Kawakami T; Kawakami F; Nishina S; Ishikawa M; Kosho T; Ishida F
    Int J Hematol; 2021 Aug; 114(2):286-291. PubMed ID: 33759087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GATA2 mutations lead to MDS and AML.
    Hyde RK; Liu PP
    Nat Genet; 2011 Sep; 43(10):926-7. PubMed ID: 21956389
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulomatous lung disease in a patient with a family history of hematological disorders.
    Overbeek MJ; van de Loosdrecht AA; Vonk-Noordegraaf A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):350-3. PubMed ID: 25591147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
    Nanaa A; Viswanatha D; Xie Z; Jevremovic D; Nguyen P; Salama ME; Greipp P; Bessonen K; Gangat N; Patnaik M; Pardanani A; Alkhateeb HB; Shah M; Hogan W; Tefferi A; Litzow M; He R; Al-Kali A
    Blood Cancer J; 2021 Jun; 11(6):122. PubMed ID: 34193836
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic heterogeneity associated with germline
    Haddox CL; Carr RM; Abraham RS; Perez Botero J; Rodriguez V; Pardanani A; Patnaik MM
    Leuk Lymphoma; 2019 Dec; 60(13):3282-3286. PubMed ID: 31246134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.